237 related articles for article (PubMed ID: 29934311)
1. p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity.
Frank SR; Köllmann CP; Luong P; Galli GG; Zou L; Bernards A; Getz G; Calogero RA; Frödin M; Hansen SH
J Cell Biol; 2018 Sep; 217(9):3183-3201. PubMed ID: 29934311
[No Abstract] [Full Text] [Related]
2. p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth.
Ouyang H; Luong P; Frödin M; Hansen SH
Oncogene; 2020 Aug; 39(33):5570-5587. PubMed ID: 32641858
[TBL] [Abstract][Full Text] [Related]
3. p120 RasGAP and ZO-2 are essential for Hippo signaling and tumor-suppressor function mediated by p190A RhoGAP.
Ouyang H; Wu S; Li W; Grey MJ; Wu W; Hansen SH
Cell Rep; 2023 Dec; 42(12):113486. PubMed ID: 37995182
[TBL] [Abstract][Full Text] [Related]
4. p190B RhoGAP regulates endothelial-cell-associated proteolysis through MT1-MMP and MMP2.
Guegan F; Tatin F; Leste-Lasserre T; Drutel G; Genot E; Moreau V
J Cell Sci; 2008 Jun; 121(Pt 12):2054-61. PubMed ID: 18505793
[TBL] [Abstract][Full Text] [Related]
5. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.
Wen X; Wan J; He Q; Wang M; Li S; Jiang M; Qian Z; Liu B; Lu W; Wang K; Gao K; Wan X
Signal Transduct Target Ther; 2020 May; 5(1):81. PubMed ID: 32457342
[TBL] [Abstract][Full Text] [Related]
6. Targeting YAP in malignant pleural mesothelioma.
Zhang WQ; Dai YY; Hsu PC; Wang H; Cheng L; Yang YL; Wang YC; Xu ZD; Liu S; Chan G; Hu B; Li H; Jablons DM; You L
J Cell Mol Med; 2017 Nov; 21(11):2663-2676. PubMed ID: 28470935
[TBL] [Abstract][Full Text] [Related]
7. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
9. Distinct but overlapping functions for the closely related p190 RhoGAPs in neural development.
Matheson SF; Hu KQ; Brouns MR; Sordella R; VanderHeide JD; Settleman J
Dev Neurosci; 2006; 28(6):538-50. PubMed ID: 17028431
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
11. p120 RasGAP and ZO-2 are essential for Hippo signaling and tumor suppressor function mediated by p190A RhoGAP.
Ouyang H; Li W; Hansen SH
bioRxiv; 2023 May; ():. PubMed ID: 37292741
[No Abstract] [Full Text] [Related]
12. Regulation of the substrate preference of p190RhoGAP by protein kinase C-mediated phosphorylation of a phospholipid binding site.
Lévay M; Settleman J; Ligeti E
Biochemistry; 2009 Sep; 48(36):8615-23. PubMed ID: 19673492
[TBL] [Abstract][Full Text] [Related]
13. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP.
Mori K; Amano M; Takefuji M; Kato K; Morita Y; Nishioka T; Matsuura Y; Murohara T; Kaibuchi K
J Biol Chem; 2009 Feb; 284(8):5067-76. PubMed ID: 19103606
[TBL] [Abstract][Full Text] [Related]
15. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
[TBL] [Abstract][Full Text] [Related]
16. A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney Defects.
Stewart K; Gaitan Y; Shafer ME; Aoudjit L; Hu D; Sharma R; Tremblay M; Ishii H; Marcotte M; Stanga D; Tang YC; Boualia SK; Nguyen AH; Takano T; Lamarche-Vane N; Vidal S; Bouchard M
PLoS Genet; 2016 Feb; 12(2):e1005785. PubMed ID: 26859289
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
18. p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration.
Jiang W; Betson M; Mulloy R; Foster R; Lévay M; Ligeti E; Settleman J
J Biol Chem; 2008 Jul; 283(30):20978-88. PubMed ID: 18502760
[TBL] [Abstract][Full Text] [Related]
19. p190A RhoGAP is involved in EGFR pathways and promotes proliferation, invasion and migration in lung adenocarcinoma cells.
Notsuda H; Sakurada A; Endo C; Okada Y; Horii A; Shima H; Kondo T
Int J Oncol; 2013 Nov; 43(5):1569-77. PubMed ID: 24043274
[TBL] [Abstract][Full Text] [Related]
20. Interaction of p190A RhoGAP with eIF3A and Other Translation Preinitiation Factors Suggests a Role in Protein Biosynthesis.
Parasuraman P; Mulligan P; Walker JA; Li B; Boukhali M; Haas W; Bernards A
J Biol Chem; 2017 Feb; 292(7):2679-2689. PubMed ID: 28007963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
